Global Therapeutic Radioisotopes Market Growth 2025-2031
The global Therapeutic Radioisotopes market size is predicted to grow from US$ 2570 million in 2025 to US$ 6153 million in 2031; it is expected to grow at a CAGR of 15.7% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Therapeutic Radioisotopes Industry Forecast” looks at past sales and reviews total world Therapeutic Radioisotopes sales in 2024, providing a comprehensive analysis by region and market sector of projected Therapeutic Radioisotopes sales for 2025 through 2031. With Therapeutic Radioisotopes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Therapeutic Radioisotopes industry.
This Insight Report provides a comprehensive analysis of the global Therapeutic Radioisotopes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Therapeutic Radioisotopes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Therapeutic Radioisotopes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Therapeutic Radioisotopes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Therapeutic Radioisotopes.
This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Radioisotopes market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Therapeutic Radioisotopes market?
What factors are driving Therapeutic Radioisotopes market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Therapeutic Radioisotopes market opportunities vary by end market size?
How does Therapeutic Radioisotopes break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the “Therapeutic Radioisotopes Industry Forecast” looks at past sales and reviews total world Therapeutic Radioisotopes sales in 2024, providing a comprehensive analysis by region and market sector of projected Therapeutic Radioisotopes sales for 2025 through 2031. With Therapeutic Radioisotopes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Therapeutic Radioisotopes industry.
This Insight Report provides a comprehensive analysis of the global Therapeutic Radioisotopes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Therapeutic Radioisotopes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Therapeutic Radioisotopes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Therapeutic Radioisotopes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Therapeutic Radioisotopes.
This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Radioisotopes market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Radium-223
- Lutetium-177
- Iodine-131
- Other
- Thyroid
- Bone Metastasis
- Lymphoma
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer
- Novartis
- China Isotope & Radiation
- Dongcheng
- Q BioMed
- Curium Pharmaceuticals
- Jubilant Radiopharma
- Lantheus
- Aurobindo Pharma
- International Isotopes
- Mundipharma
What is the 10-year outlook for the global Therapeutic Radioisotopes market?
What factors are driving Therapeutic Radioisotopes market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Therapeutic Radioisotopes market opportunities vary by end market size?
How does Therapeutic Radioisotopes break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Therapeutic Radioisotopes Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Therapeutic Radioisotopes by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Therapeutic Radioisotopes by Country/Region, 2020, 2024 & 2031
2.2 Therapeutic Radioisotopes Segment by Type
2.2.1 Radium-223
2.2.2 Lutetium-177
2.2.3 Iodine-131
2.2.4 Other
2.3 Therapeutic Radioisotopes Sales by Type
2.3.1 Global Therapeutic Radioisotopes Sales Market Share by Type (2020-2025)
2.3.2 Global Therapeutic Radioisotopes Revenue and Market Share by Type (2020-2025)
2.3.3 Global Therapeutic Radioisotopes Sale Price by Type (2020-2025)
2.4 Therapeutic Radioisotopes Segment by Application
2.4.1 Thyroid
2.4.2 Bone Metastasis
2.4.3 Lymphoma
2.4.4 Other
2.5 Therapeutic Radioisotopes Sales by Application
2.5.1 Global Therapeutic Radioisotopes Sale Market Share by Application (2020-2025)
2.5.2 Global Therapeutic Radioisotopes Revenue and Market Share by Application (2020-2025)
2.5.3 Global Therapeutic Radioisotopes Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Therapeutic Radioisotopes Breakdown Data by Company
3.1.1 Global Therapeutic Radioisotopes Annual Sales by Company (2020-2025)
3.1.2 Global Therapeutic Radioisotopes Sales Market Share by Company (2020-2025)
3.2 Global Therapeutic Radioisotopes Annual Revenue by Company (2020-2025)
3.2.1 Global Therapeutic Radioisotopes Revenue by Company (2020-2025)
3.2.2 Global Therapeutic Radioisotopes Revenue Market Share by Company (2020-2025)
3.3 Global Therapeutic Radioisotopes Sale Price by Company
3.4 Key Manufacturers Therapeutic Radioisotopes Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Therapeutic Radioisotopes Product Location Distribution
3.4.2 Players Therapeutic Radioisotopes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR THERAPEUTIC RADIOISOTOPES BY GEOGRAPHIC REGION
4.1 World Historic Therapeutic Radioisotopes Market Size by Geographic Region (2020-2025)
4.1.1 Global Therapeutic Radioisotopes Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Therapeutic Radioisotopes Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Therapeutic Radioisotopes Market Size by Country/Region (2020-2025)
4.2.1 Global Therapeutic Radioisotopes Annual Sales by Country/Region (2020-2025)
4.2.2 Global Therapeutic Radioisotopes Annual Revenue by Country/Region (2020-2025)
4.3 Americas Therapeutic Radioisotopes Sales Growth
4.4 APAC Therapeutic Radioisotopes Sales Growth
4.5 Europe Therapeutic Radioisotopes Sales Growth
4.6 Middle East & Africa Therapeutic Radioisotopes Sales Growth
5 AMERICAS
5.1 Americas Therapeutic Radioisotopes Sales by Country
5.1.1 Americas Therapeutic Radioisotopes Sales by Country (2020-2025)
5.1.2 Americas Therapeutic Radioisotopes Revenue by Country (2020-2025)
5.2 Americas Therapeutic Radioisotopes Sales by Type (2020-2025)
5.3 Americas Therapeutic Radioisotopes Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Therapeutic Radioisotopes Sales by Region
6.1.1 APAC Therapeutic Radioisotopes Sales by Region (2020-2025)
6.1.2 APAC Therapeutic Radioisotopes Revenue by Region (2020-2025)
6.2 APAC Therapeutic Radioisotopes Sales by Type (2020-2025)
6.3 APAC Therapeutic Radioisotopes Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Therapeutic Radioisotopes by Country
7.1.1 Europe Therapeutic Radioisotopes Sales by Country (2020-2025)
7.1.2 Europe Therapeutic Radioisotopes Revenue by Country (2020-2025)
7.2 Europe Therapeutic Radioisotopes Sales by Type (2020-2025)
7.3 Europe Therapeutic Radioisotopes Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Therapeutic Radioisotopes by Country
8.1.1 Middle East & Africa Therapeutic Radioisotopes Sales by Country (2020-2025)
8.1.2 Middle East & Africa Therapeutic Radioisotopes Revenue by Country (2020-2025)
8.2 Middle East & Africa Therapeutic Radioisotopes Sales by Type (2020-2025)
8.3 Middle East & Africa Therapeutic Radioisotopes Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Therapeutic Radioisotopes
10.3 Manufacturing Process Analysis of Therapeutic Radioisotopes
10.4 Industry Chain Structure of Therapeutic Radioisotopes
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Therapeutic Radioisotopes Distributors
11.3 Therapeutic Radioisotopes Customer
12 WORLD FORECAST REVIEW FOR THERAPEUTIC RADIOISOTOPES BY GEOGRAPHIC REGION
12.1 Global Therapeutic Radioisotopes Market Size Forecast by Region
12.1.1 Global Therapeutic Radioisotopes Forecast by Region (2026-2031)
12.1.2 Global Therapeutic Radioisotopes Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Therapeutic Radioisotopes Forecast by Type (2026-2031)
12.7 Global Therapeutic Radioisotopes Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Therapeutic Radioisotopes Product Portfolios and Specifications
13.1.3 Bayer Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Therapeutic Radioisotopes Product Portfolios and Specifications
13.2.3 Novartis Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 China Isotope & Radiation
13.3.1 China Isotope & Radiation Company Information
13.3.2 China Isotope & Radiation Therapeutic Radioisotopes Product Portfolios and Specifications
13.3.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 China Isotope & Radiation Main Business Overview
13.3.5 China Isotope & Radiation Latest Developments
13.4 Dongcheng
13.4.1 Dongcheng Company Information
13.4.2 Dongcheng Therapeutic Radioisotopes Product Portfolios and Specifications
13.4.3 Dongcheng Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Dongcheng Main Business Overview
13.4.5 Dongcheng Latest Developments
13.5 Q BioMed
13.5.1 Q BioMed Company Information
13.5.2 Q BioMed Therapeutic Radioisotopes Product Portfolios and Specifications
13.5.3 Q BioMed Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Q BioMed Main Business Overview
13.5.5 Q BioMed Latest Developments
13.6 Curium Pharmaceuticals
13.6.1 Curium Pharmaceuticals Company Information
13.6.2 Curium Pharmaceuticals Therapeutic Radioisotopes Product Portfolios and Specifications
13.6.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Curium Pharmaceuticals Main Business Overview
13.6.5 Curium Pharmaceuticals Latest Developments
13.7 Jubilant Radiopharma
13.7.1 Jubilant Radiopharma Company Information
13.7.2 Jubilant Radiopharma Therapeutic Radioisotopes Product Portfolios and Specifications
13.7.3 Jubilant Radiopharma Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Jubilant Radiopharma Main Business Overview
13.7.5 Jubilant Radiopharma Latest Developments
13.8 Lantheus
13.8.1 Lantheus Company Information
13.8.2 Lantheus Therapeutic Radioisotopes Product Portfolios and Specifications
13.8.3 Lantheus Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Lantheus Main Business Overview
13.8.5 Lantheus Latest Developments
13.9 Aurobindo Pharma
13.9.1 Aurobindo Pharma Company Information
13.9.2 Aurobindo Pharma Therapeutic Radioisotopes Product Portfolios and Specifications
13.9.3 Aurobindo Pharma Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Aurobindo Pharma Main Business Overview
13.9.5 Aurobindo Pharma Latest Developments
13.10 International Isotopes
13.10.1 International Isotopes Company Information
13.10.2 International Isotopes Therapeutic Radioisotopes Product Portfolios and Specifications
13.10.3 International Isotopes Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 International Isotopes Main Business Overview
13.10.5 International Isotopes Latest Developments
13.11 Mundipharma
13.11.1 Mundipharma Company Information
13.11.2 Mundipharma Therapeutic Radioisotopes Product Portfolios and Specifications
13.11.3 Mundipharma Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Mundipharma Main Business Overview
13.11.5 Mundipharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Therapeutic Radioisotopes Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Therapeutic Radioisotopes by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Therapeutic Radioisotopes by Country/Region, 2020, 2024 & 2031
2.2 Therapeutic Radioisotopes Segment by Type
2.2.1 Radium-223
2.2.2 Lutetium-177
2.2.3 Iodine-131
2.2.4 Other
2.3 Therapeutic Radioisotopes Sales by Type
2.3.1 Global Therapeutic Radioisotopes Sales Market Share by Type (2020-2025)
2.3.2 Global Therapeutic Radioisotopes Revenue and Market Share by Type (2020-2025)
2.3.3 Global Therapeutic Radioisotopes Sale Price by Type (2020-2025)
2.4 Therapeutic Radioisotopes Segment by Application
2.4.1 Thyroid
2.4.2 Bone Metastasis
2.4.3 Lymphoma
2.4.4 Other
2.5 Therapeutic Radioisotopes Sales by Application
2.5.1 Global Therapeutic Radioisotopes Sale Market Share by Application (2020-2025)
2.5.2 Global Therapeutic Radioisotopes Revenue and Market Share by Application (2020-2025)
2.5.3 Global Therapeutic Radioisotopes Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Therapeutic Radioisotopes Breakdown Data by Company
3.1.1 Global Therapeutic Radioisotopes Annual Sales by Company (2020-2025)
3.1.2 Global Therapeutic Radioisotopes Sales Market Share by Company (2020-2025)
3.2 Global Therapeutic Radioisotopes Annual Revenue by Company (2020-2025)
3.2.1 Global Therapeutic Radioisotopes Revenue by Company (2020-2025)
3.2.2 Global Therapeutic Radioisotopes Revenue Market Share by Company (2020-2025)
3.3 Global Therapeutic Radioisotopes Sale Price by Company
3.4 Key Manufacturers Therapeutic Radioisotopes Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Therapeutic Radioisotopes Product Location Distribution
3.4.2 Players Therapeutic Radioisotopes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR THERAPEUTIC RADIOISOTOPES BY GEOGRAPHIC REGION
4.1 World Historic Therapeutic Radioisotopes Market Size by Geographic Region (2020-2025)
4.1.1 Global Therapeutic Radioisotopes Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Therapeutic Radioisotopes Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Therapeutic Radioisotopes Market Size by Country/Region (2020-2025)
4.2.1 Global Therapeutic Radioisotopes Annual Sales by Country/Region (2020-2025)
4.2.2 Global Therapeutic Radioisotopes Annual Revenue by Country/Region (2020-2025)
4.3 Americas Therapeutic Radioisotopes Sales Growth
4.4 APAC Therapeutic Radioisotopes Sales Growth
4.5 Europe Therapeutic Radioisotopes Sales Growth
4.6 Middle East & Africa Therapeutic Radioisotopes Sales Growth
5 AMERICAS
5.1 Americas Therapeutic Radioisotopes Sales by Country
5.1.1 Americas Therapeutic Radioisotopes Sales by Country (2020-2025)
5.1.2 Americas Therapeutic Radioisotopes Revenue by Country (2020-2025)
5.2 Americas Therapeutic Radioisotopes Sales by Type (2020-2025)
5.3 Americas Therapeutic Radioisotopes Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Therapeutic Radioisotopes Sales by Region
6.1.1 APAC Therapeutic Radioisotopes Sales by Region (2020-2025)
6.1.2 APAC Therapeutic Radioisotopes Revenue by Region (2020-2025)
6.2 APAC Therapeutic Radioisotopes Sales by Type (2020-2025)
6.3 APAC Therapeutic Radioisotopes Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Therapeutic Radioisotopes by Country
7.1.1 Europe Therapeutic Radioisotopes Sales by Country (2020-2025)
7.1.2 Europe Therapeutic Radioisotopes Revenue by Country (2020-2025)
7.2 Europe Therapeutic Radioisotopes Sales by Type (2020-2025)
7.3 Europe Therapeutic Radioisotopes Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Therapeutic Radioisotopes by Country
8.1.1 Middle East & Africa Therapeutic Radioisotopes Sales by Country (2020-2025)
8.1.2 Middle East & Africa Therapeutic Radioisotopes Revenue by Country (2020-2025)
8.2 Middle East & Africa Therapeutic Radioisotopes Sales by Type (2020-2025)
8.3 Middle East & Africa Therapeutic Radioisotopes Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Therapeutic Radioisotopes
10.3 Manufacturing Process Analysis of Therapeutic Radioisotopes
10.4 Industry Chain Structure of Therapeutic Radioisotopes
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Therapeutic Radioisotopes Distributors
11.3 Therapeutic Radioisotopes Customer
12 WORLD FORECAST REVIEW FOR THERAPEUTIC RADIOISOTOPES BY GEOGRAPHIC REGION
12.1 Global Therapeutic Radioisotopes Market Size Forecast by Region
12.1.1 Global Therapeutic Radioisotopes Forecast by Region (2026-2031)
12.1.2 Global Therapeutic Radioisotopes Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Therapeutic Radioisotopes Forecast by Type (2026-2031)
12.7 Global Therapeutic Radioisotopes Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Therapeutic Radioisotopes Product Portfolios and Specifications
13.1.3 Bayer Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Therapeutic Radioisotopes Product Portfolios and Specifications
13.2.3 Novartis Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 China Isotope & Radiation
13.3.1 China Isotope & Radiation Company Information
13.3.2 China Isotope & Radiation Therapeutic Radioisotopes Product Portfolios and Specifications
13.3.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 China Isotope & Radiation Main Business Overview
13.3.5 China Isotope & Radiation Latest Developments
13.4 Dongcheng
13.4.1 Dongcheng Company Information
13.4.2 Dongcheng Therapeutic Radioisotopes Product Portfolios and Specifications
13.4.3 Dongcheng Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Dongcheng Main Business Overview
13.4.5 Dongcheng Latest Developments
13.5 Q BioMed
13.5.1 Q BioMed Company Information
13.5.2 Q BioMed Therapeutic Radioisotopes Product Portfolios and Specifications
13.5.3 Q BioMed Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Q BioMed Main Business Overview
13.5.5 Q BioMed Latest Developments
13.6 Curium Pharmaceuticals
13.6.1 Curium Pharmaceuticals Company Information
13.6.2 Curium Pharmaceuticals Therapeutic Radioisotopes Product Portfolios and Specifications
13.6.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Curium Pharmaceuticals Main Business Overview
13.6.5 Curium Pharmaceuticals Latest Developments
13.7 Jubilant Radiopharma
13.7.1 Jubilant Radiopharma Company Information
13.7.2 Jubilant Radiopharma Therapeutic Radioisotopes Product Portfolios and Specifications
13.7.3 Jubilant Radiopharma Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Jubilant Radiopharma Main Business Overview
13.7.5 Jubilant Radiopharma Latest Developments
13.8 Lantheus
13.8.1 Lantheus Company Information
13.8.2 Lantheus Therapeutic Radioisotopes Product Portfolios and Specifications
13.8.3 Lantheus Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Lantheus Main Business Overview
13.8.5 Lantheus Latest Developments
13.9 Aurobindo Pharma
13.9.1 Aurobindo Pharma Company Information
13.9.2 Aurobindo Pharma Therapeutic Radioisotopes Product Portfolios and Specifications
13.9.3 Aurobindo Pharma Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Aurobindo Pharma Main Business Overview
13.9.5 Aurobindo Pharma Latest Developments
13.10 International Isotopes
13.10.1 International Isotopes Company Information
13.10.2 International Isotopes Therapeutic Radioisotopes Product Portfolios and Specifications
13.10.3 International Isotopes Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 International Isotopes Main Business Overview
13.10.5 International Isotopes Latest Developments
13.11 Mundipharma
13.11.1 Mundipharma Company Information
13.11.2 Mundipharma Therapeutic Radioisotopes Product Portfolios and Specifications
13.11.3 Mundipharma Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Mundipharma Main Business Overview
13.11.5 Mundipharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Therapeutic Radioisotopes Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Therapeutic Radioisotopes Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Radium-223
Table 4. Major Players of Lutetium-177
Table 5. Major Players of Iodine-131
Table 6. Major Players of Other
Table 7. Global Therapeutic Radioisotopes Sales by Type (2020-2025) & (K Units)
Table 8. Global Therapeutic Radioisotopes Sales Market Share by Type (2020-2025)
Table 9. Global Therapeutic Radioisotopes Revenue by Type (2020-2025) & ($ million)
Table 10. Global Therapeutic Radioisotopes Revenue Market Share by Type (2020-2025)
Table 11. Global Therapeutic Radioisotopes Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Therapeutic Radioisotopes Sale by Application (2020-2025) & (K Units)
Table 13. Global Therapeutic Radioisotopes Sale Market Share by Application (2020-2025)
Table 14. Global Therapeutic Radioisotopes Revenue by Application (2020-2025) & ($ million)
Table 15. Global Therapeutic Radioisotopes Revenue Market Share by Application (2020-2025)
Table 16. Global Therapeutic Radioisotopes Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Therapeutic Radioisotopes Sales by Company (2020-2025) & (K Units)
Table 18. Global Therapeutic Radioisotopes Sales Market Share by Company (2020-2025)
Table 19. Global Therapeutic Radioisotopes Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Therapeutic Radioisotopes Revenue Market Share by Company (2020-2025)
Table 21. Global Therapeutic Radioisotopes Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Therapeutic Radioisotopes Producing Area Distribution and Sales Area
Table 23. Players Therapeutic Radioisotopes Products Offered
Table 24. Therapeutic Radioisotopes Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Therapeutic Radioisotopes Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Therapeutic Radioisotopes Sales Market Share Geographic Region (2020-2025)
Table 29. Global Therapeutic Radioisotopes Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Therapeutic Radioisotopes Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Therapeutic Radioisotopes Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Therapeutic Radioisotopes Sales Market Share by Country/Region (2020-2025)
Table 33. Global Therapeutic Radioisotopes Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Therapeutic Radioisotopes Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Therapeutic Radioisotopes Sales by Country (2020-2025) & (K Units)
Table 36. Americas Therapeutic Radioisotopes Sales Market Share by Country (2020-2025)
Table 37. Americas Therapeutic Radioisotopes Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Therapeutic Radioisotopes Sales by Type (2020-2025) & (K Units)
Table 39. Americas Therapeutic Radioisotopes Sales by Application (2020-2025) & (K Units)
Table 40. APAC Therapeutic Radioisotopes Sales by Region (2020-2025) & (K Units)
Table 41. APAC Therapeutic Radioisotopes Sales Market Share by Region (2020-2025)
Table 42. APAC Therapeutic Radioisotopes Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Therapeutic Radioisotopes Sales by Type (2020-2025) & (K Units)
Table 44. APAC Therapeutic Radioisotopes Sales by Application (2020-2025) & (K Units)
Table 45. Europe Therapeutic Radioisotopes Sales by Country (2020-2025) & (K Units)
Table 46. Europe Therapeutic Radioisotopes Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Therapeutic Radioisotopes Sales by Type (2020-2025) & (K Units)
Table 48. Europe Therapeutic Radioisotopes Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Therapeutic Radioisotopes Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Therapeutic Radioisotopes Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Therapeutic Radioisotopes Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Therapeutic Radioisotopes Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Therapeutic Radioisotopes
Table 54. Key Market Challenges & Risks of Therapeutic Radioisotopes
Table 55. Key Industry Trends of Therapeutic Radioisotopes
Table 56. Therapeutic Radioisotopes Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Therapeutic Radioisotopes Distributors List
Table 59. Therapeutic Radioisotopes Customer List
Table 60. Global Therapeutic Radioisotopes Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Therapeutic Radioisotopes Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Therapeutic Radioisotopes Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Therapeutic Radioisotopes Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Therapeutic Radioisotopes Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Therapeutic Radioisotopes Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Therapeutic Radioisotopes Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Therapeutic Radioisotopes Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Therapeutic Radioisotopes Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Therapeutic Radioisotopes Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Therapeutic Radioisotopes Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Therapeutic Radioisotopes Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Therapeutic Radioisotopes Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Therapeutic Radioisotopes Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Bayer Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 75. Bayer Therapeutic Radioisotopes Product Portfolios and Specifications
Table 76. Bayer Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Bayer Main Business
Table 78. Bayer Latest Developments
Table 79. Novartis Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis Therapeutic Radioisotopes Product Portfolios and Specifications
Table 81. Novartis Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Novartis Main Business
Table 83. Novartis Latest Developments
Table 84. China Isotope & Radiation Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 85. China Isotope & Radiation Therapeutic Radioisotopes Product Portfolios and Specifications
Table 86. China Isotope & Radiation Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China Isotope & Radiation Main Business
Table 88. China Isotope & Radiation Latest Developments
Table 89. Dongcheng Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 90. Dongcheng Therapeutic Radioisotopes Product Portfolios and Specifications
Table 91. Dongcheng Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Dongcheng Main Business
Table 93. Dongcheng Latest Developments
Table 94. Q BioMed Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 95. Q BioMed Therapeutic Radioisotopes Product Portfolios and Specifications
Table 96. Q BioMed Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Q BioMed Main Business
Table 98. Q BioMed Latest Developments
Table 99. Curium Pharmaceuticals Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 100. Curium Pharmaceuticals Therapeutic Radioisotopes Product Portfolios and Specifications
Table 101. Curium Pharmaceuticals Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Curium Pharmaceuticals Main Business
Table 103. Curium Pharmaceuticals Latest Developments
Table 104. Jubilant Radiopharma Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 105. Jubilant Radiopharma Therapeutic Radioisotopes Product Portfolios and Specifications
Table 106. Jubilant Radiopharma Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Jubilant Radiopharma Main Business
Table 108. Jubilant Radiopharma Latest Developments
Table 109. Lantheus Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 110. Lantheus Therapeutic Radioisotopes Product Portfolios and Specifications
Table 111. Lantheus Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Lantheus Main Business
Table 113. Lantheus Latest Developments
Table 114. Aurobindo Pharma Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 115. Aurobindo Pharma Therapeutic Radioisotopes Product Portfolios and Specifications
Table 116. Aurobindo Pharma Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Aurobindo Pharma Main Business
Table 118. Aurobindo Pharma Latest Developments
Table 119. International Isotopes Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 120. International Isotopes Therapeutic Radioisotopes Product Portfolios and Specifications
Table 121. International Isotopes Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. International Isotopes Main Business
Table 123. International Isotopes Latest Developments
Table 124. Mundipharma Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 125. Mundipharma Therapeutic Radioisotopes Product Portfolios and Specifications
Table 126. Mundipharma Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Mundipharma Main Business
Table 128. Mundipharma Latest Developments
Table 1. Therapeutic Radioisotopes Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Therapeutic Radioisotopes Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Radium-223
Table 4. Major Players of Lutetium-177
Table 5. Major Players of Iodine-131
Table 6. Major Players of Other
Table 7. Global Therapeutic Radioisotopes Sales by Type (2020-2025) & (K Units)
Table 8. Global Therapeutic Radioisotopes Sales Market Share by Type (2020-2025)
Table 9. Global Therapeutic Radioisotopes Revenue by Type (2020-2025) & ($ million)
Table 10. Global Therapeutic Radioisotopes Revenue Market Share by Type (2020-2025)
Table 11. Global Therapeutic Radioisotopes Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Therapeutic Radioisotopes Sale by Application (2020-2025) & (K Units)
Table 13. Global Therapeutic Radioisotopes Sale Market Share by Application (2020-2025)
Table 14. Global Therapeutic Radioisotopes Revenue by Application (2020-2025) & ($ million)
Table 15. Global Therapeutic Radioisotopes Revenue Market Share by Application (2020-2025)
Table 16. Global Therapeutic Radioisotopes Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Therapeutic Radioisotopes Sales by Company (2020-2025) & (K Units)
Table 18. Global Therapeutic Radioisotopes Sales Market Share by Company (2020-2025)
Table 19. Global Therapeutic Radioisotopes Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Therapeutic Radioisotopes Revenue Market Share by Company (2020-2025)
Table 21. Global Therapeutic Radioisotopes Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Therapeutic Radioisotopes Producing Area Distribution and Sales Area
Table 23. Players Therapeutic Radioisotopes Products Offered
Table 24. Therapeutic Radioisotopes Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Therapeutic Radioisotopes Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Therapeutic Radioisotopes Sales Market Share Geographic Region (2020-2025)
Table 29. Global Therapeutic Radioisotopes Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Therapeutic Radioisotopes Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Therapeutic Radioisotopes Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Therapeutic Radioisotopes Sales Market Share by Country/Region (2020-2025)
Table 33. Global Therapeutic Radioisotopes Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Therapeutic Radioisotopes Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Therapeutic Radioisotopes Sales by Country (2020-2025) & (K Units)
Table 36. Americas Therapeutic Radioisotopes Sales Market Share by Country (2020-2025)
Table 37. Americas Therapeutic Radioisotopes Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Therapeutic Radioisotopes Sales by Type (2020-2025) & (K Units)
Table 39. Americas Therapeutic Radioisotopes Sales by Application (2020-2025) & (K Units)
Table 40. APAC Therapeutic Radioisotopes Sales by Region (2020-2025) & (K Units)
Table 41. APAC Therapeutic Radioisotopes Sales Market Share by Region (2020-2025)
Table 42. APAC Therapeutic Radioisotopes Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Therapeutic Radioisotopes Sales by Type (2020-2025) & (K Units)
Table 44. APAC Therapeutic Radioisotopes Sales by Application (2020-2025) & (K Units)
Table 45. Europe Therapeutic Radioisotopes Sales by Country (2020-2025) & (K Units)
Table 46. Europe Therapeutic Radioisotopes Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Therapeutic Radioisotopes Sales by Type (2020-2025) & (K Units)
Table 48. Europe Therapeutic Radioisotopes Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Therapeutic Radioisotopes Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Therapeutic Radioisotopes Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Therapeutic Radioisotopes Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Therapeutic Radioisotopes Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Therapeutic Radioisotopes
Table 54. Key Market Challenges & Risks of Therapeutic Radioisotopes
Table 55. Key Industry Trends of Therapeutic Radioisotopes
Table 56. Therapeutic Radioisotopes Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Therapeutic Radioisotopes Distributors List
Table 59. Therapeutic Radioisotopes Customer List
Table 60. Global Therapeutic Radioisotopes Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Therapeutic Radioisotopes Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Therapeutic Radioisotopes Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Therapeutic Radioisotopes Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Therapeutic Radioisotopes Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Therapeutic Radioisotopes Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Therapeutic Radioisotopes Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Therapeutic Radioisotopes Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Therapeutic Radioisotopes Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Therapeutic Radioisotopes Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Therapeutic Radioisotopes Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Therapeutic Radioisotopes Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Therapeutic Radioisotopes Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Therapeutic Radioisotopes Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Bayer Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 75. Bayer Therapeutic Radioisotopes Product Portfolios and Specifications
Table 76. Bayer Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Bayer Main Business
Table 78. Bayer Latest Developments
Table 79. Novartis Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 80. Novartis Therapeutic Radioisotopes Product Portfolios and Specifications
Table 81. Novartis Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Novartis Main Business
Table 83. Novartis Latest Developments
Table 84. China Isotope & Radiation Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 85. China Isotope & Radiation Therapeutic Radioisotopes Product Portfolios and Specifications
Table 86. China Isotope & Radiation Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China Isotope & Radiation Main Business
Table 88. China Isotope & Radiation Latest Developments
Table 89. Dongcheng Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 90. Dongcheng Therapeutic Radioisotopes Product Portfolios and Specifications
Table 91. Dongcheng Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Dongcheng Main Business
Table 93. Dongcheng Latest Developments
Table 94. Q BioMed Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 95. Q BioMed Therapeutic Radioisotopes Product Portfolios and Specifications
Table 96. Q BioMed Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Q BioMed Main Business
Table 98. Q BioMed Latest Developments
Table 99. Curium Pharmaceuticals Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 100. Curium Pharmaceuticals Therapeutic Radioisotopes Product Portfolios and Specifications
Table 101. Curium Pharmaceuticals Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Curium Pharmaceuticals Main Business
Table 103. Curium Pharmaceuticals Latest Developments
Table 104. Jubilant Radiopharma Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 105. Jubilant Radiopharma Therapeutic Radioisotopes Product Portfolios and Specifications
Table 106. Jubilant Radiopharma Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Jubilant Radiopharma Main Business
Table 108. Jubilant Radiopharma Latest Developments
Table 109. Lantheus Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 110. Lantheus Therapeutic Radioisotopes Product Portfolios and Specifications
Table 111. Lantheus Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Lantheus Main Business
Table 113. Lantheus Latest Developments
Table 114. Aurobindo Pharma Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 115. Aurobindo Pharma Therapeutic Radioisotopes Product Portfolios and Specifications
Table 116. Aurobindo Pharma Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Aurobindo Pharma Main Business
Table 118. Aurobindo Pharma Latest Developments
Table 119. International Isotopes Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 120. International Isotopes Therapeutic Radioisotopes Product Portfolios and Specifications
Table 121. International Isotopes Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. International Isotopes Main Business
Table 123. International Isotopes Latest Developments
Table 124. Mundipharma Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 125. Mundipharma Therapeutic Radioisotopes Product Portfolios and Specifications
Table 126. Mundipharma Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Mundipharma Main Business
Table 128. Mundipharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Therapeutic Radioisotopes
Figure 2. Therapeutic Radioisotopes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Therapeutic Radioisotopes Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Therapeutic Radioisotopes Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Therapeutic Radioisotopes Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Therapeutic Radioisotopes Sales Market Share by Country/Region (2024)
Figure 10. Therapeutic Radioisotopes Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Radium-223
Figure 12. Product Picture of Lutetium-177
Figure 13. Product Picture of Iodine-131
Figure 14. Product Picture of Other
Figure 15. Global Therapeutic Radioisotopes Sales Market Share by Type in 2025
Figure 16. Global Therapeutic Radioisotopes Revenue Market Share by Type (2020-2025)
Figure 17. Therapeutic Radioisotopes Consumed in Thyroid
Figure 18. Global Therapeutic Radioisotopes Market: Thyroid (2020-2025) & (K Units)
Figure 19. Therapeutic Radioisotopes Consumed in Bone Metastasis
Figure 20. Global Therapeutic Radioisotopes Market: Bone Metastasis (2020-2025) & (K Units)
Figure 21. Therapeutic Radioisotopes Consumed in Lymphoma
Figure 22. Global Therapeutic Radioisotopes Market: Lymphoma (2020-2025) & (K Units)
Figure 23. Therapeutic Radioisotopes Consumed in Other
Figure 24. Global Therapeutic Radioisotopes Market: Other (2020-2025) & (K Units)
Figure 25. Global Therapeutic Radioisotopes Sale Market Share by Application (2024)
Figure 26. Global Therapeutic Radioisotopes Revenue Market Share by Application in 2025
Figure 27. Therapeutic Radioisotopes Sales by Company in 2025 (K Units)
Figure 28. Global Therapeutic Radioisotopes Sales Market Share by Company in 2025
Figure 29. Therapeutic Radioisotopes Revenue by Company in 2025 ($ millions)
Figure 30. Global Therapeutic Radioisotopes Revenue Market Share by Company in 2025
Figure 31. Global Therapeutic Radioisotopes Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Therapeutic Radioisotopes Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Therapeutic Radioisotopes Sales 2020-2025 (K Units)
Figure 34. Americas Therapeutic Radioisotopes Revenue 2020-2025 ($ millions)
Figure 35. APAC Therapeutic Radioisotopes Sales 2020-2025 (K Units)
Figure 36. APAC Therapeutic Radioisotopes Revenue 2020-2025 ($ millions)
Figure 37. Europe Therapeutic Radioisotopes Sales 2020-2025 (K Units)
Figure 38. Europe Therapeutic Radioisotopes Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Therapeutic Radioisotopes Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Therapeutic Radioisotopes Revenue 2020-2025 ($ millions)
Figure 41. Americas Therapeutic Radioisotopes Sales Market Share by Country in 2025
Figure 42. Americas Therapeutic Radioisotopes Revenue Market Share by Country (2020-2025)
Figure 43. Americas Therapeutic Radioisotopes Sales Market Share by Type (2020-2025)
Figure 44. Americas Therapeutic Radioisotopes Sales Market Share by Application (2020-2025)
Figure 45. United States Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Therapeutic Radioisotopes Sales Market Share by Region in 2025
Figure 50. APAC Therapeutic Radioisotopes Revenue Market Share by Region (2020-2025)
Figure 51. APAC Therapeutic Radioisotopes Sales Market Share by Type (2020-2025)
Figure 52. APAC Therapeutic Radioisotopes Sales Market Share by Application (2020-2025)
Figure 53. China Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 57. India Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Therapeutic Radioisotopes Sales Market Share by Country in 2025
Figure 61. Europe Therapeutic Radioisotopes Revenue Market Share by Country (2020-2025)
Figure 62. Europe Therapeutic Radioisotopes Sales Market Share by Type (2020-2025)
Figure 63. Europe Therapeutic Radioisotopes Sales Market Share by Application (2020-2025)
Figure 64. Germany Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 65. France Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Therapeutic Radioisotopes Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Therapeutic Radioisotopes Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Therapeutic Radioisotopes Sales Market Share by Application (2020-2025)
Figure 72. Egypt Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Therapeutic Radioisotopes in 2025
Figure 78. Manufacturing Process Analysis of Therapeutic Radioisotopes
Figure 79. Industry Chain Structure of Therapeutic Radioisotopes
Figure 80. Channels of Distribution
Figure 81. Global Therapeutic Radioisotopes Sales Market Forecast by Region (2026-2031)
Figure 82. Global Therapeutic Radioisotopes Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Therapeutic Radioisotopes Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Therapeutic Radioisotopes Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Therapeutic Radioisotopes Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Therapeutic Radioisotopes Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Therapeutic Radioisotopes
Figure 2. Therapeutic Radioisotopes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Therapeutic Radioisotopes Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Therapeutic Radioisotopes Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Therapeutic Radioisotopes Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Therapeutic Radioisotopes Sales Market Share by Country/Region (2024)
Figure 10. Therapeutic Radioisotopes Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Radium-223
Figure 12. Product Picture of Lutetium-177
Figure 13. Product Picture of Iodine-131
Figure 14. Product Picture of Other
Figure 15. Global Therapeutic Radioisotopes Sales Market Share by Type in 2025
Figure 16. Global Therapeutic Radioisotopes Revenue Market Share by Type (2020-2025)
Figure 17. Therapeutic Radioisotopes Consumed in Thyroid
Figure 18. Global Therapeutic Radioisotopes Market: Thyroid (2020-2025) & (K Units)
Figure 19. Therapeutic Radioisotopes Consumed in Bone Metastasis
Figure 20. Global Therapeutic Radioisotopes Market: Bone Metastasis (2020-2025) & (K Units)
Figure 21. Therapeutic Radioisotopes Consumed in Lymphoma
Figure 22. Global Therapeutic Radioisotopes Market: Lymphoma (2020-2025) & (K Units)
Figure 23. Therapeutic Radioisotopes Consumed in Other
Figure 24. Global Therapeutic Radioisotopes Market: Other (2020-2025) & (K Units)
Figure 25. Global Therapeutic Radioisotopes Sale Market Share by Application (2024)
Figure 26. Global Therapeutic Radioisotopes Revenue Market Share by Application in 2025
Figure 27. Therapeutic Radioisotopes Sales by Company in 2025 (K Units)
Figure 28. Global Therapeutic Radioisotopes Sales Market Share by Company in 2025
Figure 29. Therapeutic Radioisotopes Revenue by Company in 2025 ($ millions)
Figure 30. Global Therapeutic Radioisotopes Revenue Market Share by Company in 2025
Figure 31. Global Therapeutic Radioisotopes Sales Market Share by Geographic Region (2020-2025)
Figure 32. Global Therapeutic Radioisotopes Revenue Market Share by Geographic Region in 2025
Figure 33. Americas Therapeutic Radioisotopes Sales 2020-2025 (K Units)
Figure 34. Americas Therapeutic Radioisotopes Revenue 2020-2025 ($ millions)
Figure 35. APAC Therapeutic Radioisotopes Sales 2020-2025 (K Units)
Figure 36. APAC Therapeutic Radioisotopes Revenue 2020-2025 ($ millions)
Figure 37. Europe Therapeutic Radioisotopes Sales 2020-2025 (K Units)
Figure 38. Europe Therapeutic Radioisotopes Revenue 2020-2025 ($ millions)
Figure 39. Middle East & Africa Therapeutic Radioisotopes Sales 2020-2025 (K Units)
Figure 40. Middle East & Africa Therapeutic Radioisotopes Revenue 2020-2025 ($ millions)
Figure 41. Americas Therapeutic Radioisotopes Sales Market Share by Country in 2025
Figure 42. Americas Therapeutic Radioisotopes Revenue Market Share by Country (2020-2025)
Figure 43. Americas Therapeutic Radioisotopes Sales Market Share by Type (2020-2025)
Figure 44. Americas Therapeutic Radioisotopes Sales Market Share by Application (2020-2025)
Figure 45. United States Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 46. Canada Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 47. Mexico Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 48. Brazil Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 49. APAC Therapeutic Radioisotopes Sales Market Share by Region in 2025
Figure 50. APAC Therapeutic Radioisotopes Revenue Market Share by Region (2020-2025)
Figure 51. APAC Therapeutic Radioisotopes Sales Market Share by Type (2020-2025)
Figure 52. APAC Therapeutic Radioisotopes Sales Market Share by Application (2020-2025)
Figure 53. China Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 54. Japan Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 55. South Korea Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast Asia Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 57. India Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 58. Australia Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 59. China Taiwan Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 60. Europe Therapeutic Radioisotopes Sales Market Share by Country in 2025
Figure 61. Europe Therapeutic Radioisotopes Revenue Market Share by Country (2020-2025)
Figure 62. Europe Therapeutic Radioisotopes Sales Market Share by Type (2020-2025)
Figure 63. Europe Therapeutic Radioisotopes Sales Market Share by Application (2020-2025)
Figure 64. Germany Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 65. France Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 66. UK Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 67. Italy Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 68. Russia Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & Africa Therapeutic Radioisotopes Sales Market Share by Country (2020-2025)
Figure 70. Middle East & Africa Therapeutic Radioisotopes Sales Market Share by Type (2020-2025)
Figure 71. Middle East & Africa Therapeutic Radioisotopes Sales Market Share by Application (2020-2025)
Figure 72. Egypt Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 73. South Africa Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 74. Israel Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 75. Turkey Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC Countries Therapeutic Radioisotopes Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis of Therapeutic Radioisotopes in 2025
Figure 78. Manufacturing Process Analysis of Therapeutic Radioisotopes
Figure 79. Industry Chain Structure of Therapeutic Radioisotopes
Figure 80. Channels of Distribution
Figure 81. Global Therapeutic Radioisotopes Sales Market Forecast by Region (2026-2031)
Figure 82. Global Therapeutic Radioisotopes Revenue Market Share Forecast by Region (2026-2031)
Figure 83. Global Therapeutic Radioisotopes Sales Market Share Forecast by Type (2026-2031)
Figure 84. Global Therapeutic Radioisotopes Revenue Market Share Forecast by Type (2026-2031)
Figure 85. Global Therapeutic Radioisotopes Sales Market Share Forecast by Application (2026-2031)
Figure 86. Global Therapeutic Radioisotopes Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Ketorolac Tromethamine Market Growth 2025-2031
US$ 3,660.00
December 2025
111 pages
Global Moxifloxacin HCl Market Growth 2025-2031
US$ 3,660.00
January 2025
91 pages
Global Postoperative Pain Management Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
110 pages
Global Contract Development and Manufacturing Organization (CDMO) Outsourcing Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
93 pages
